Agenda
Welcome and Introduction
Johann Gudjonsson, MD, PhD, United States
Nick Reynolds, BSc, MBBS, MD, FRCP, United Kingdom
The Comparative Pathogenesis of Psoriasis and Atopic Dermatitis
Johann Gudjonsson, MD, PhD, United States
Phenotype Switching
Michel Gilliet, MD, Switzerland
Genetic and Ethnic Differences in Psoriasis and Atopic Dermatitis
Sara Brown, MBChB, MD, United Kingdom
Panel Discussion
Faculty
BREAK
Abstract Presentations
Epigenetic and Transcriptomic Characterization of Skin Homing CLA+ CD4+ T-Cells in Atopic Dermatitis and Psoriasis
Ana Rebane, PhD – Instititute of Biomedicine and Translational
Medicine, University of Tartu, Tartu, Estonia
Protective Effects of Systemic Therapies for Psoriasis Against Thrombotic Events
Alison Treichel, MD – University Hospitals Cleveland Medical Center,
Cleveland, Ohio, United States
Reduced Filaggrin Expression Reduces ERK Signalling and Disrupts Desmosomes in Atopic Eczema
Ryan O’Shaughnessy, PhD – Centre for Cell BIology and Cutaneous
Research, Queen Mary University of London, London, United Kingdom
The Effect of Age on the Severity of Psoriasis
Shir Azrielant, MD – St John’s Institute of Dermatology, King’s College
London, London, United Kingdom
Smart Imaging and Deep Learning for Objective Psoriasis Lesion Scoring: A Scarletred Proof-of-Concept Study
Monika Molnarova, MSc – SCARLETRED Holding GmbH, Vienna,
Austria
Using Biomarkers to Inform the Treatment of Atopic Dermatitis
Marjolein Bruin-Weller, MD, PhD, Netherlands
Using Biomarkers to Inform the Treatment of Psoriasis
Satveer Mahil, PhD, MRCP, United Kingdom
Using Biomarkers to Assess the Risk of Comorbidities in Atopic Dermatitis
Christian Vestergaard, MD, PhD, DMSc, Denmark
Using Biomarkers to Assess the Risk of Comorbidities in Psoriasis
Catherine Smith, MD, United Kingdom
Panel Discussion
Faculty
Closing Comments
Akimichi Morita, MD, PhD, Nagoya, Japan
Tiago Torres, MD, PhD, Portugal
Program Chairs
Johann Gudjonsson, MD, PhD
University of Michigan, Department of Dermatology
Ann Arbor, Michigan, United States
IPC Board Member
Akimichi Morita, MD, PhD
Nagoya City University West Medical Center and Nagoya City University Graduate School of Medical Sciences
Nagoya, Japan
IPC Board Member
Nick Reynolds, BSc, MBBS, MD, FRCP
Newcastle University
Newcastle upon Tyne, United Kingdom
IPC Councilor
Tiago Torres, MD, PhD
Centro Hospitalar Universitário de Santo António, University of Porto
Porto, Portugal
IPC Councilor
Program Faculty
Symposium jointly presented with:
This symposium is supported in part by:
The sponsorship is provided exclusively to the IPC.